• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-126:癌症与运动之间的桥梁。

miR-126: a bridge between cancer and exercise.

作者信息

Liu Zhengqiong, Ke Shanbin, Wan Yuwen

机构信息

College of Education, Jiangxi Institute of Applied Science and Technology, Nanchang, 330100, China.

出版信息

Cancer Cell Int. 2025 Apr 15;25(1):145. doi: 10.1186/s12935-025-03784-0.

DOI:10.1186/s12935-025-03784-0
PMID:40234897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11998190/
Abstract

The microRNA miR-126 supports endothelial cells and blood vessel integrity. Recent research has shown that it also serves as a key link between exercise and cancer. This article delves into how exercise affects the expression of miR-126, impacting cardiovascular well-being and metabolic control. The article also examines the various contributions of miR-126 in cancer, acting as both a suppressor and an enhancer depending on the particular context. Regular aerobic exercises, including HIIT, consistently increase levels of miR-126, leading to enhanced angiogenesis, endothelial repair, and improved vascular function through mechanisms involving VEGF, HIF-1α, and EPC mobilization. Resistance training affects similar pathways, but does not cause a significant change in miR-126 levels.MiR-126 involves in cancer by suppressing tumor growth and controlling key pathways such as PI3K/Akt, ERK/MAPK, and EMT. Lower levels are associated with negative outcomes, later stages of the disease, and increased spread of different types of cancer like glioblastoma, CRC, ovarian, esophageal, gastric, and prostate cancer.The relationship between exercise and cancer suggests a possible therapeutic approach, where the regulation of miR-126 through exercise could help improve vascular function and slow tumor growth. Further studies should focus on understanding the specific molecular pathways through which miR-126 connects these areas, leading to potential interventions that utilize its regulatory network to promote cardiovascular well-being and enhance cancer treatment.

摘要

微小RNA miR - 126维持内皮细胞和血管完整性。近期研究表明,它也是运动与癌症之间的关键联系。本文深入探讨运动如何影响miR - 126的表达,进而影响心血管健康和代谢控制。文章还研究了miR - 126在癌症中的各种作用,根据具体情况,它既可以作为抑制因子,也可以作为增强因子。包括高强度间歇训练(HIIT)在内的常规有氧运动持续增加miR - 126水平,通过涉及血管内皮生长因子(VEGF)、低氧诱导因子 - 1α(HIF - 1α)和内皮祖细胞(EPC)动员的机制,导致血管生成增强、内皮修复改善和血管功能提升。抗阻训练影响类似途径,但不会使miR - 126水平发生显著变化。MiR - 126通过抑制肿瘤生长和控制关键信号通路如PI3K/Akt、ERK/MAPK和上皮 - 间质转化(EMT)参与癌症发生。较低水平与不良预后、疾病晚期以及不同类型癌症(如胶质母细胞瘤、结直肠癌、卵巢癌、食管癌、胃癌和前列腺癌)的扩散增加有关。运动与癌症之间的关系提示了一种可能的治疗方法,即通过运动调节miR - 126有助于改善血管功能和减缓肿瘤生长。进一步的研究应聚焦于了解miR - 126连接这些领域的具体分子途径,从而产生利用其调控网络促进心血管健康和增强癌症治疗效果的潜在干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8791/11998190/c6fd032da139/12935_2025_3784_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8791/11998190/c6fd032da139/12935_2025_3784_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8791/11998190/c6fd032da139/12935_2025_3784_Fig1_HTML.jpg

相似文献

1
miR-126: a bridge between cancer and exercise.微小RNA-126:癌症与运动之间的桥梁。
Cancer Cell Int. 2025 Apr 15;25(1):145. doi: 10.1186/s12935-025-03784-0.
2
MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression.miR-21 通过激活 AKT 和 ERK 以及表达 HIF-1α 诱导血管生成。
PLoS One. 2011 Apr 22;6(4):e19139. doi: 10.1371/journal.pone.0019139.
3
microRNA-646 inhibits angiogenesis of endothelial progenitor cells in pre-eclamptic pregnancy by targeting the VEGF-A/HIF-1α axis.微小RNA-646通过靶向血管内皮生长因子A/缺氧诱导因子-1α轴抑制子痫前期妊娠中内皮祖细胞的血管生成。
Exp Ther Med. 2020 Sep;20(3):1879-1888. doi: 10.3892/etm.2020.8929. Epub 2020 Jun 24.
4
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.微小RNA-497通过PI3K/AKT和MAPK/ERK信号通路靶向血管内皮生长因子A抑制卵巢癌血管生成。
Oncol Rep. 2014 Nov;32(5):2127-33. doi: 10.3892/or.2014.3439. Epub 2014 Aug 22.
5
Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes.体育锻炼诱导的MiR-126在2型糖尿病心血管健康中的作用。
Diabetol Metab Syndr. 2022 Nov 14;14(1):169. doi: 10.1186/s13098-022-00942-6.
6
miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.miR-148a 通过在非缺氧/缺氧条件下间接靶向 HIF-1α 抑制早期复发性结直肠癌和 VEGF 的分泌。
J Cell Mol Med. 2019 May;23(5):3572-3582. doi: 10.1111/jcmm.14257. Epub 2019 Mar 4.
7
MicroRNA-206, let-7a and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer.微小RNA-206、let-7a和微小RNA-21通路参与了间歇运动训练和激素疗法对乳腺癌的抗血管生成作用。
Life Sci. 2016 Apr 15;151:30-40. doi: 10.1016/j.lfs.2016.02.090. Epub 2016 Feb 26.
8
HIF-1α-induced up-regulation of microRNA-126 contributes to the effectiveness of exercise training on myocardial angiogenesis in myocardial infarction rats.低氧诱导因子-1α诱导的 microRNA-126 上调有助于运动训练对心肌梗死后大鼠心肌血管生成的作用。
J Cell Mol Med. 2020 Nov;24(22):12970-12979. doi: 10.1111/jcmm.15892. Epub 2020 Sep 16.
9
The epigallocatechin gallate derivative Y inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways.没食子酸表没食子儿茶素酯衍生物 Y 通过抑制 MAPK/ERK1/2 和 PI3K/AKT/HIF-1α/VEGF 依赖性通路抑制血管生成来抑制人肝癌。
J Ethnopharmacol. 2020 Sep 15;259:112852. doi: 10.1016/j.jep.2020.112852. Epub 2020 Apr 9.
10
Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes endothelial cell angiogenesis by regulating the miR-140-3p/HIF-1α/VEGF signaling axis.源自结直肠癌相关成纤维细胞的外泌体circ_0084043通过调节miR-140-3p/HIF-1α/VEGF信号轴促进内皮细胞血管生成。
Heliyon. 2024 May 20;10(11):e31584. doi: 10.1016/j.heliyon.2024.e31584. eCollection 2024 Jun 15.

引用本文的文献

1
MicroRNA-126 as an endogenous molecule for hypoxic/ischemic tolerance in neuroprotection.微小RNA-126作为神经保护中缺氧/缺血耐受的内源性分子。
Neurol Sci. 2025 Aug 23. doi: 10.1007/s10072-025-08413-2.

本文引用的文献

1
RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer.RNA 调控机制控制癌症中的 TGF-β 信号和 EMT。
Semin Cancer Biol. 2024 Jul;102-103:4-16. doi: 10.1016/j.semcancer.2024.06.001. Epub 2024 Jun 23.
2
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Notch 信号通路与癌症:从机制研究到靶向治疗。
Signal Transduct Target Ther. 2024 May 27;9(1):128. doi: 10.1038/s41392-024-01828-x.
3
The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function.
长链非编码RNA和环状RNA在宫颈癌中的作用:调节miRNA功能
Front Cell Dev Biol. 2024 Feb 16;12:1308730. doi: 10.3389/fcell.2024.1308730. eCollection 2024.
4
MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy [Retraction].微小RNA-126通过抑制mTOR诱导的凋亡和自噬抑制结肠癌细胞活力[撤回]
Onco Targets Ther. 2024 Feb 20;17:129-130. doi: 10.2147/OTT.S464377. eCollection 2024.
5
Exercise as a Promising Agent against Cancer: Evaluating Its Anti-Cancer Molecular Mechanisms.运动作为一种有前景的抗癌因子:评估其抗癌分子机制
Cancers (Basel). 2023 Oct 25;15(21):5135. doi: 10.3390/cancers15215135.
6
The emerging role of microRNA-126 as a potential therapeutic target in cancer: a comprehensive review.微小 RNA-126 作为癌症潜在治疗靶点的新兴作用:全面综述。
Pathol Res Pract. 2023 Aug;248:154631. doi: 10.1016/j.prp.2023.154631. Epub 2023 Jun 19.
7
The Notch signaling pathway: a potential target for cancer immunotherapy.Notch 信号通路:癌症免疫治疗的潜在靶点。
J Hematol Oncol. 2023 May 2;16(1):45. doi: 10.1186/s13045-023-01439-z.
8
miRNA Biogenesis and Regulation of Diseases: An Updated Overview.miRNA 的生物发生与疾病调控:最新综述
Methods Mol Biol. 2023;2595:1-12. doi: 10.1007/978-1-0716-2823-2_1.
9
Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes.体育锻炼诱导的MiR-126在2型糖尿病心血管健康中的作用。
Diabetol Metab Syndr. 2022 Nov 14;14(1):169. doi: 10.1186/s13098-022-00942-6.
10
Killing two birds with one stone: miR-126 involvement in both cancer and atherosclerosis.一石二鸟:miR-126 同时参与癌症和动脉粥样硬化。
Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6145-6168. doi: 10.26355/eurrev_202209_29632.